Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial.
BMJ Open. 2019 Oct 07;9(10):e031092
A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy.
Breast. 2019 Aug 22;48:17-23
Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trial.
BMJ Open. 2019 May 10;9(5):e024485
Eur J Hum Genet. 2019 Mar 08;:
Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Support Care Cancer. 2019 Jan 04;:
BMC Med Genomics. 2018 Aug 09;11(1):65
Association of Metabolic, Inflammatory, and Tumor Markers With Circulating Tumor Cells in Metastatic Breast Cancer.
JNCI Cancer Spectr. 2018 Apr;2(2):pky028
Ther Innov Regul Sci. 2018 Jan 01;:2168479018784910
Oncology education for Canadian internal medicine residents: the value of participating in a medical oncology elective rotation.
Curr Oncol. 2018 Jun;25(3):213-218
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial.
BMJ Open. 2018 Apr 26;8(4):e021876